RT Journal Article
SR Electronic
A1 Sinclair, Heather Q.
T1 How Does Dabigatran Compare with Warfarin for Secondary Stroke Prevention? Subgroup Analysis of the RE-LY Study
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 1
SP 14
OP 15
DO 10.1177/155989771001005
UL http://mdc.sagepub.com/content/10/1/14.abstract
AB A subgroup analysis of the Randomized Evaluation of Long-term anticoagulant therapy [RE-LY; NCT00262600] trial revealed that dabigatran 110 mg or 150 mg twice daily is as effective as warfarin for stroke prevention in patients who have had a prior stroke or transient ischemic attack.